ZNF212
gene geneOn this page
Also known as C2H2-150
Summary
ZNF212 (zinc finger protein 212, HGNC:13004) is a protein-coding gene on chromosome 7q36.1, encoding Zinc finger protein 212 (Q9UDV6). May be involved in transcriptional regulation.
This gene belongs to the C2H2-type zinc finger gene family. The zinc finger proteins are involved in gene regulation and development, and are quite conserved throughout evolution. Like this gene product, a third of the zinc finger proteins containing C2H2 fingers also contain the KRAB domain, which has been found to be involved in protein-protein interactions.
Source: NCBI Gene 7988 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 99 total — 1 pathogenic
- MANE Select transcript:
NM_012256
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13004 |
| Approved symbol | ZNF212 |
| Name | zinc finger protein 212 |
| Location | 7q36.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | C2H2-150 |
| Ensembl gene | ENSG00000170260 |
| Ensembl biotype | protein_coding |
| OMIM | 602386 |
| Entrez | 7988 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 3 protein_coding, 3 nonsense_mediated_decay
ENST00000335870, ENST00000462724, ENST00000481584, ENST00000486371, ENST00000488917, ENST00000877956
RefSeq mRNA: 1 — MANE Select: NM_012256
NM_012256
CCDS: CCDS5896
Canonical transcript exons
ENST00000335870 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001235949 | 149239651 | 149239802 |
| ENSE00001361371 | 149253559 | 149255606 |
| ENSE00001361374 | 149250681 | 149250807 |
| ENSE00001361376 | 149250159 | 149250548 |
| ENSE00003516176 | 149252706 | 149252795 |
Expression profiles
Bgee: expression breadth ubiquitous, 280 present calls, max score 90.63.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 7.2213 / max 73.3363, expressed in 1770 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 81888 | 7.2213 | 1770 |
Top tissues by expression
293 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| lower esophagus mucosa | UBERON:0035834 | 90.63 | gold quality |
| buccal mucosa cell | CL:0002336 | 89.61 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 89.00 | silver quality |
| oviduct epithelium | UBERON:0004804 | 88.85 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 86.27 | gold quality |
| parotid gland | UBERON:0001831 | 86.25 | gold quality |
| cervix epithelium | UBERON:0004801 | 85.53 | silver quality |
| cervix squamous epithelium | UBERON:0006922 | 84.64 | silver quality |
| renal medulla | UBERON:0000362 | 84.37 | gold quality |
| fallopian tube | UBERON:0003889 | 84.15 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 84.14 | silver quality |
| cartilage tissue | UBERON:0002418 | 84.11 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.99 | gold quality |
| granulocyte | CL:0000094 | 83.87 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 83.87 | silver quality |
| tongue | UBERON:0001723 | 83.84 | silver quality |
| body of tongue | UBERON:0011876 | 83.77 | silver quality |
| superior surface of tongue | UBERON:0007371 | 83.74 | silver quality |
| cardia of stomach | UBERON:0001162 | 83.69 | silver quality |
| esophagus mucosa | UBERON:0002469 | 83.56 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 83.54 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 83.42 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 83.29 | silver quality |
| epithelium of esophagus | UBERON:0001976 | 83.24 | gold quality |
| pancreatic ductal cell | CL:0002079 | 83.20 | silver quality |
| nipple | UBERON:0002030 | 83.19 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 83.16 | silver quality |
| pylorus | UBERON:0001166 | 83.14 | gold quality |
| ventricular zone | UBERON:0003053 | 83.14 | gold quality |
| secondary oocyte | CL:0000655 | 83.04 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.26 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
41 targeting ZNF212, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-218-5P | 99.93 | 72.22 | 2103 |
| HSA-MIR-4495 | 99.82 | 72.08 | 3080 |
| HSA-MIR-6875-3P | 99.82 | 70.26 | 2983 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-1283 | 99.69 | 72.42 | 3009 |
| HSA-MIR-1249-5P | 99.61 | 66.55 | 2049 |
| HSA-MIR-6797-5P | 99.61 | 66.55 | 2084 |
| HSA-MIR-6128 | 99.33 | 67.83 | 1581 |
| HSA-MIR-4311 | 99.31 | 70.47 | 3041 |
| HSA-MIR-888-5P | 99.30 | 70.15 | 1855 |
| HSA-MIR-4667-3P | 99.26 | 65.45 | 1608 |
| HSA-MIR-361-3P | 99.19 | 66.45 | 1381 |
| HSA-MIR-4263 | 99.18 | 69.25 | 2236 |
| HSA-MIR-3619-5P | 99.00 | 68.87 | 2308 |
| HSA-MIR-214-3P | 98.71 | 68.12 | 2128 |
| HSA-MIR-761 | 98.71 | 68.07 | 2051 |
| HSA-MIR-518C-5P | 98.53 | 69.20 | 1640 |
| HSA-MIR-1470 | 98.11 | 63.53 | 399 |
| HSA-MIR-4469 | 97.93 | 65.81 | 1319 |
| HSA-MIR-449C-3P | 97.75 | 67.86 | 462 |
| HSA-MIR-4675 | 97.69 | 64.82 | 774 |
| HSA-MIR-4741 | 97.69 | 64.14 | 883 |
| HSA-MIR-6793-3P | 97.66 | 65.78 | 1084 |
Literature-anchored findings (GeneRIF, showing 1)
- ZNF212 promotes genomic integrity through direct interaction with TRAIP. (PMID:36594163)
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | znf574 | ENSDARG00000087074 |
| mus_musculus | Zfp212 | ENSMUSG00000052763 |
| rattus_norvegicus | Zfp212 | ENSRNOG00000006711 |
| drosophila_melanogaster | CG11902 | FBGN0028647 |
| drosophila_melanogaster | CG11696 | FBGN0030314 |
| drosophila_melanogaster | CG10631 | FBGN0032817 |
Paralogs (7): ZNF671 (ENSG00000083814), ZNF710 (ENSG00000140548), ZNF366 (ENSG00000178175), ZNF662 (ENSG00000182983), ZNF667 (ENSG00000198046), ZNF783 (ENSG00000204946), ZNF865 (ENSG00000261221)
Protein
Protein identifiers
Zinc finger protein 212 — Q9UDV6 (reviewed: Q9UDV6)
Alternative names: Zinc finger protein C2H2-150
All UniProt accessions (5): Q9UDV6, A0A090N8N3, F2Z3G9, H7C589, H7C5A9
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_036388* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352, PF13912
UniProt features (12 total): zinc finger region 4, region of interest 4, chain 1, domain 1, compositionally biased region 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9UDV6-F1 | 54.75 | 0.14 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 117 (showing top):
GSE45365_NK_CELL_VS_CD11B_DC_UP, GOBP_DENDRITE_DEVELOPMENT, GOBP_BEHAVIOR, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, GOBP_NEUROGENESIS, SHIPP_DLBCL_CURED_VS_FATAL_DN, GOBP_NEUROMUSCULAR_PROCESS_CONTROLLING_BALANCE, GOBP_MULTICELLULAR_ORGANISMAL_RESPONSE_TO_STRESS, MODULE_120, GOBP_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND, AGGAGTG_MIR483, GOBP_NEURON_APOPTOTIC_PROCESS, SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP, MODULE_175
GO Biological Process (9): regulation of DNA-templated transcription (GO:0006355), regulation of transcription by RNA polymerase II (GO:0006357), dendrite development (GO:0016358), positive regulation of transcription by RNA polymerase II (GO:0045944), neuromuscular process controlling balance (GO:0050885), neuron apoptotic process (GO:0051402), general adaptation syndrome, behavioral process (GO:0051867), walking behavior (GO:0090659), response to alcohol (GO:0097305)
GO Molecular Function (8): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228), DNA-binding transcription factor activity (GO:0003700), zinc ion binding (GO:0008270), identical protein binding (GO:0042802), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (2): nucleus (GO:0005634), nucleoplasm (GO:0005654)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| transcription by RNA polymerase II | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| neuron projection development | 1 |
| anatomical structure development | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| positive regulation of DNA-templated transcription | 1 |
| musculoskeletal movement | 1 |
| neuromuscular process | 1 |
| apoptotic process | 1 |
| behavior | 1 |
| general adaptation syndrome | 1 |
| locomotory behavior | 1 |
| response to oxygen-containing compound | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 1 |
| DNA-binding transcription activator activity | 1 |
| positive regulation of transcription by RNA polymerase II | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| transition metal ion binding | 1 |
| protein binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1128 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF212 | OR10H2 | O60403 | 508 |
| ZNF212 | SPACA5B | Q96QH8 | 472 |
| ZNF212 | ZNF579 | Q8NAF0 | 464 |
| ZNF212 | C7orf33 | Q8WU49 | 447 |
| ZNF212 | ZNF487 | B1APH4 | 446 |
| ZNF212 | DRC11L | A6NCM1 | 433 |
| ZNF212 | A0A087WTJ2 | A0A087WTJ2 | 399 |
| ZNF212 | WDR86 | Q86TI4 | 399 |
| ZNF212 | ZBED10P | Q96FA7 | 392 |
| ZNF212 | TRIM28 | Q13263 | 372 |
| ZNF212 | AGAP3 | Q96P47 | 371 |
| ZNF212 | LRRC61 | Q9BV99 | 370 |
| ZNF212 | ZNF474 | Q6S9Z5 | 359 |
| ZNF212 | CXorf38 | Q8TB03 | 358 |
| ZNF212 | ZNF862 | O60290 | 329 |
IntAct
89 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FAM90A1 | ZNF212 | psi-mi:“MI:0915”(physical association) | 0.780 |
| ZNF212 | FAM90A1 | psi-mi:“MI:0915”(physical association) | 0.780 |
| ZNF212 | SF3A3 | psi-mi:“MI:0915”(physical association) | 0.670 |
| SF3A3 | ZNF212 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ZNF783 | ZNF212 | psi-mi:“MI:0915”(physical association) | 0.640 |
| ZNF212 | ZNF783 | psi-mi:“MI:0915”(physical association) | 0.640 |
| ZNF212 | PRP45 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GCD7 | ZNF212 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TAE1 | ZNF212 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRP45 | ZNF212 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF212 | GCD7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF212 | TAE1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM161B | ZNF212 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MFAP1 | ZNF212 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (72): SF3A3 (Two-hybrid), FAM90A1 (Two-hybrid), LOC155060 (Two-hybrid), ZNF212 (Affinity Capture-MS), ADO (Affinity Capture-MS), ZNF398 (Affinity Capture-MS), ZNF282 (Affinity Capture-MS), ZNF746 (Affinity Capture-MS), ZNF212 (Affinity Capture-MS), EPDR1 (Affinity Capture-MS), ZNF777 (Affinity Capture-MS), DIS3 (Affinity Capture-MS), ZNF212 (Two-hybrid), ZNF212 (Two-hybrid), ZNF212 (Two-hybrid)
ESM2 similar proteins: A0A1D5NS60, A0JN76, A1YFX5, A2T7G6, A6NJL1, D2HQI1, F1MJR8, O14901, P0CG00, P10754, P22227, P98182, Q0IJ29, Q1L8W0, Q3SWU4, Q5DW34, Q5EAC5, Q5EXX3, Q5RHB5, Q5SXI5, Q5T619, Q66H04, Q6NRM8, Q6NV66, Q6ZSB9, Q7M6U3, Q7TS63, Q7TSH3, Q7ZWZ4, Q801P1, Q86VK4, Q8BKX7, Q8BXX2, Q8NAM6, Q8NAP3, Q8NCP5, Q8R0A2, Q91VW9, Q96IT1, Q96N77
Diamond homologs: A0A9P4XV22, A2ANX9, B1H2Q6, O62836, P08048, P0CJ78, P10925, P17010, P17012, P20662, P27705, P28698, P52288, P80944, Q01611, Q03081, Q03125, Q0VDT2, Q29419, Q3U3I9, Q52V16, Q567C6, Q5U2Z0, Q6B4Z5, Q7RTV3, Q95LI3, Q966L8, Q96EG3, Q9UDV6, Q9UL36, Q9Y462, B0K011, B0X9H6, E9Q6W4, O75362, O77459, P31509, P60319, P86413, Q01798
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
99 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 81 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 3062962 | GRCh37/hg19 7q36.1(chr7:148896264-150963866)x1 | Pathogenic |
SpliceAI
1805 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:149239723:G:GT | donor_gain | 1.0000 |
| 7:149239724:A:T | donor_gain | 1.0000 |
| 7:149250497:G:GT | donor_gain | 1.0000 |
| 7:149250498:A:T | donor_gain | 1.0000 |
| 7:149250778:A:T | donor_gain | 1.0000 |
| 7:149250785:C:G | donor_gain | 1.0000 |
| 7:149250803:TCTGA:T | donor_gain | 1.0000 |
| 7:149250804:CTGA:C | donor_gain | 1.0000 |
| 7:149250805:TGA:T | donor_gain | 1.0000 |
| 7:149250806:GA:G | donor_gain | 1.0000 |
| 7:149250806:GAG:G | donor_gain | 1.0000 |
| 7:149250807:AG:A | donor_loss | 1.0000 |
| 7:149250808:G:GG | donor_gain | 1.0000 |
| 7:149250811:AGTAG:A | donor_loss | 1.0000 |
| 7:149239798:CTCGG:C | donor_loss | 0.9900 |
| 7:149239799:TCGG:T | donor_loss | 0.9900 |
| 7:149239800:CGG:C | donor_loss | 0.9900 |
| 7:149239804:T:C | donor_loss | 0.9900 |
| 7:149250157:A:AG | acceptor_gain | 0.9900 |
| 7:149250158:G:GG | acceptor_gain | 0.9900 |
| 7:149250158:GC:G | acceptor_gain | 0.9900 |
| 7:149250158:GCACA:G | acceptor_gain | 0.9900 |
| 7:149250544:CCAAG:C | donor_loss | 0.9900 |
| 7:149250545:CAAG:C | donor_loss | 0.9900 |
| 7:149250546:AAGGT:A | donor_loss | 0.9900 |
| 7:149250547:AGG:A | donor_loss | 0.9900 |
| 7:149250548:GGTAG:G | donor_loss | 0.9900 |
| 7:149250549:GT:G | donor_loss | 0.9900 |
| 7:149250550:T:A | donor_loss | 0.9900 |
| 7:149250779:GA:G | donor_gain | 0.9900 |
AlphaMissense
3220 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:149254317:T:C | F464L | 1.000 |
| 7:149254319:T:A | F464L | 1.000 |
| 7:149254319:T:G | F464L | 1.000 |
| 7:149254233:T:C | F436L | 0.999 |
| 7:149254235:C:A | F436L | 0.999 |
| 7:149254235:C:G | F436L | 0.999 |
| 7:149254318:T:C | F464S | 0.999 |
| 7:149254336:T:C | L470P | 0.999 |
| 7:149254344:C:G | H473D | 0.999 |
| 7:149254346:C:A | H473Q | 0.999 |
| 7:149254346:C:G | H473Q | 0.999 |
| 7:149254260:C:G | H445D | 0.998 |
| 7:149254262:C:A | H445Q | 0.998 |
| 7:149254262:C:G | H445Q | 0.998 |
| 7:149254267:G:C | R447P | 0.998 |
| 7:149254272:C:G | H449D | 0.998 |
| 7:149254274:C:A | H449Q | 0.998 |
| 7:149254274:C:G | H449Q | 0.998 |
| 7:149254296:T:C | C457R | 0.998 |
| 7:149254318:T:G | F464C | 0.998 |
| 7:149254344:C:A | H473N | 0.998 |
| 7:149254059:T:C | F378L | 0.997 |
| 7:149254061:C:A | F378L | 0.997 |
| 7:149254061:C:G | F378L | 0.997 |
| 7:149254223:T:G | C432W | 0.997 |
| 7:149254234:T:C | F436S | 0.997 |
| 7:149254260:C:A | H445N | 0.997 |
| 7:149254264:A:C | Q446P | 0.997 |
| 7:149254348:A:C | Q474P | 0.997 |
| 7:149254356:C:G | H477D | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000037160 (7:149240821 A>G), RS1000095419 (7:149242354 A>G), RS1000128124 (7:149242006 TTTTTCTTTTC>T,TTTTTC,TTTTTCTTTTCTTTTC), RS1000267570 (7:149252610 C>T), RS1000318756 (7:149239865 G>C), RS1001591580 (7:149238823 T>G), RS1001749850 (7:149244405 C>G,T), RS1001802087 (7:149244230 C>T), RS1001924438 (7:149238557 G>A,C,T), RS1001971610 (7:149253045 G>A,C,T), RS1002002526 (7:149252792 C>T), RS1002020533 (7:149249905 A>C), RS1002141114 (7:149242742 A>G,T), RS1002175595 (7:149246814 T>C), RS1002242959 (7:149249554 A>T)
Disease associations
OMIM: gene MIM:602386 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009391_1423 | Metabolite levels | 4.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0010452 | adenosine diphosphate measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| GSK-J4 | increases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| beta-methylcholine | affects expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| abrine | increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Fulvestrant | increases methylation | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Selenium | affects cotreatment, increases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Urethane | increases expression | 1 |
| Vitamin E | affects cotreatment, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.